Reclassifying erectile dysfunction drug sildenafil as a pharmacy medicine would not be such a huge leapSubscription
Allowing pharmacists to sell sildenafil would offer men a convenient, safe, and perhaps less intimidating, channel for seeking professional advice and treatment for erectile dysfunction.
We outline some of the issues pharmacists might like to consider before they cast their vote in the UK general election on 8 June 2017.
While the implications of Brexit on drug regulation in the UK are largely unknown, the government needs to consider its options quickly to avoid delaying public access to important medicine.
The new urgent medicine supply scheme from NHS England requires more thought and revision.
Your RPS needs youSubscription
Show your passion and dedication to pharmacy by putting yourself forward for this year’s RPS national pharmacy board elections.
Recommendations made in Murray’s review for community pharmacy will not be simple to implementSubscription
Practical challenges, including building closer relationships with GPs, will need to be overcome if the recommendations in the Murray review on community pharmacy are to be implemented successfully.
We need fewer empty promises and more action and progress with rebalancing medicines legislation and pharmacy regulation — particularly around dispensing errors.